vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and REGIS CORP (RGS). Click either name above to swap in a different company.

REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $41.9M, roughly 1.4× ARVINAS, INC.). REGIS CORP runs the higher net margin — 0.8% vs -83.8%, a 84.6% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs -59.1%). REGIS CORP produced more free cash flow last quarter ($891.0K vs $-59.2M). Over the past eight quarters, ARVINAS, INC.'s revenue compounded faster (10.0% CAGR vs 7.8%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.

ARVN vs RGS — Head-to-Head

Bigger by revenue
RGS
RGS
1.4× larger
RGS
$57.1M
$41.9M
ARVN
Growing faster (revenue YoY)
RGS
RGS
+81.3% gap
RGS
22.3%
-59.1%
ARVN
Higher net margin
RGS
RGS
84.6% more per $
RGS
0.8%
-83.8%
ARVN
More free cash flow
RGS
RGS
$60.1M more FCF
RGS
$891.0K
$-59.2M
ARVN
Faster 2-yr revenue CAGR
ARVN
ARVN
Annualised
ARVN
10.0%
7.8%
RGS

Income Statement — Q3 FY2025 vs Q2 FY2026

Metric
ARVN
ARVN
RGS
RGS
Revenue
$41.9M
$57.1M
Net Profit
$-35.1M
$456.0K
Gross Margin
Operating Margin
-104.5%
10.8%
Net Margin
-83.8%
0.8%
Revenue YoY
-59.1%
22.3%
Net Profit YoY
28.7%
-94.0%
EPS (diluted)
$-0.48
$0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
RGS
RGS
Q4 25
$57.1M
Q3 25
$41.9M
$59.0M
Q2 25
$60.4M
Q1 25
$188.8M
$57.0M
Q4 24
$59.2M
$46.7M
Q3 24
$102.4M
$46.1M
Q2 24
$76.5M
$49.4M
Q1 24
$25.3M
$49.2M
Net Profit
ARVN
ARVN
RGS
RGS
Q4 25
$456.0K
Q3 25
$-35.1M
$1.4M
Q2 25
$116.5M
Q1 25
$82.9M
$250.0K
Q4 24
$-45.1M
$7.6M
Q3 24
$-49.2M
$-853.0K
Q2 24
$-35.2M
$91.2M
Q1 24
$-69.4M
$-2.3M
Operating Margin
ARVN
ARVN
RGS
RGS
Q4 25
10.8%
Q3 25
-104.5%
10.0%
Q2 25
12.1%
Q1 25
37.8%
8.8%
Q4 24
-98.1%
11.8%
Q3 24
-58.9%
4.6%
Q2 24
-63.4%
Q1 24
-329.2%
8.3%
Net Margin
ARVN
ARVN
RGS
RGS
Q4 25
0.8%
Q3 25
-83.8%
2.3%
Q2 25
192.9%
Q1 25
43.9%
0.4%
Q4 24
-76.2%
16.4%
Q3 24
-48.0%
-1.9%
Q2 24
-46.0%
184.7%
Q1 24
-274.3%
-4.7%
EPS (diluted)
ARVN
ARVN
RGS
RGS
Q4 25
$0.16
Q3 25
$-0.48
$0.49
Q2 25
$43.67
Q1 25
$1.14
$0.08
Q4 24
$-0.63
$2.71
Q3 24
$-0.68
$-0.36
Q2 24
$-0.49
$38.40
Q1 24
$-0.97
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
RGS
RGS
Cash + ST InvestmentsLiquidity on hand
$787.6M
$18.4M
Total DebtLower is stronger
$600.0K
$113.3M
Stockholders' EquityBook value
$564.4M
$188.7M
Total Assets
$844.3M
$588.3M
Debt / EquityLower = less leverage
0.00×
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
RGS
RGS
Q4 25
$18.4M
Q3 25
$787.6M
$16.6M
Q2 25
$17.0M
Q1 25
$954.3M
$13.3M
Q4 24
$1.0B
$10.2M
Q3 24
$1.1B
$6.3M
Q2 24
$1.2B
$10.1M
Q1 24
$1.2B
$5.9M
Total Debt
ARVN
ARVN
RGS
RGS
Q4 25
$113.3M
Q3 25
$600.0K
$111.3M
Q2 25
$110.8M
Q1 25
$700.0K
$112.0M
Q4 24
$800.0K
$111.5M
Q3 24
$800.0K
$95.2M
Q2 24
$900.0K
$99.5M
Q1 24
$900.0K
$179.7M
Stockholders' Equity
ARVN
ARVN
RGS
RGS
Q4 25
$188.7M
Q3 25
$564.4M
$187.6M
Q2 25
$185.6M
Q1 25
$660.1M
$68.6M
Q4 24
$561.7M
$66.7M
Q3 24
$586.0M
$56.4M
Q2 24
$600.2M
$56.8M
Q1 24
$609.7M
$-35.8M
Total Assets
ARVN
ARVN
RGS
RGS
Q4 25
$588.3M
Q3 25
$844.3M
$592.1M
Q2 25
$599.0M
Q1 25
$1.0B
$511.2M
Q4 24
$1.1B
$530.1M
Q3 24
$1.2B
$508.9M
Q2 24
$1.3B
$530.5M
Q1 24
$1.2B
$543.7M
Debt / Equity
ARVN
ARVN
RGS
RGS
Q4 25
0.60×
Q3 25
0.00×
0.59×
Q2 25
0.60×
Q1 25
0.00×
1.63×
Q4 24
0.00×
1.67×
Q3 24
0.00×
1.69×
Q2 24
0.00×
1.75×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
RGS
RGS
Operating Cash FlowLast quarter
$-59.1M
$1.7M
Free Cash FlowOCF − Capex
$-59.2M
$891.0K
FCF MarginFCF / Revenue
-141.3%
1.6%
Capex IntensityCapex / Revenue
0.2%
1.4%
Cash ConversionOCF / Net Profit
3.65×
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
RGS
RGS
Q4 25
$1.7M
Q3 25
$-59.1M
$2.3M
Q2 25
$6.8M
Q1 25
$-88.9M
$6.2M
Q4 24
$-84.1M
$2.1M
Q3 24
$-128.0M
$-1.3M
Q2 24
$50.3M
$5.1M
Q1 24
$-97.5M
$-277.0K
Free Cash Flow
ARVN
ARVN
RGS
RGS
Q4 25
$891.0K
Q3 25
$-59.2M
$1.9M
Q2 25
$6.2M
Q1 25
$-89.3M
$5.9M
Q4 24
$-84.4M
$1.7M
Q3 24
$-128.7M
$-1.4M
Q2 24
$49.6M
$5.1M
Q1 24
$-97.6M
$-326.0K
FCF Margin
ARVN
ARVN
RGS
RGS
Q4 25
1.6%
Q3 25
-141.3%
3.2%
Q2 25
10.3%
Q1 25
-47.3%
10.3%
Q4 24
-142.6%
3.6%
Q3 24
-125.7%
-3.0%
Q2 24
64.8%
10.3%
Q1 24
-385.8%
-0.7%
Capex Intensity
ARVN
ARVN
RGS
RGS
Q4 25
1.4%
Q3 25
0.2%
0.7%
Q2 25
0.9%
Q1 25
0.2%
0.6%
Q4 24
0.5%
0.9%
Q3 24
0.7%
0.0%
Q2 24
0.9%
0.0%
Q1 24
0.4%
0.1%
Cash Conversion
ARVN
ARVN
RGS
RGS
Q4 25
3.65×
Q3 25
1.68×
Q2 25
0.06×
Q1 25
-1.07×
24.80×
Q4 24
0.28×
Q3 24
Q2 24
0.06×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARVN
ARVN

Segment breakdown not available.

RGS
RGS

Franchise Segment$37.9M66%
Royalty$13.6M24%
Other$2.8M5%
Fees$1.8M3%
Franchise Fees$1.0M2%

Related Comparisons